| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |